Westchester Capital Management (New York)’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-197,927
Closed -$1.97M 410
2021
Q3
$1.97M Buy
+197,927
New +$1.97M 0.06% 165